SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-21-150527
Filing Date
2021-12-16
Accepted
2021-12-16 16:16:22
Documents
1
Period of Report
2021-12-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2135616d1_4a.html 4/A  
1 OWNERSHIP DOCUMENT tm2135616d1_4a.xml 4/A 4515
  Complete submission text file 0001104659-21-150527.txt   6156
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address
Rombotis Spiro George (Reporting) CIK: 0001357396 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-50626 | Film No.: 211497965